Hemodialysis vascular access: Variable thrombus-free survival in three subpopulations of black patients

American Journal of Kidney Diseases

Volumn 31, Issue 2, 1998, Pages 250-256

  Obialo, Chamberlain I ^a   Robinson, Thelma ^a   Brathwaite, Michel ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Access survival; AIDS nephropathy; Blacks; Focal glomerulosclerosis; Hemodialysis vascular access; Hypertension; Thrombosis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOCAL GLOMERULONEPHRITIS; GRAFT PATENCY; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; MALE; NEGRO; THROMBOSIS; VASCULAR ACCESS;

EID: 0031932464     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v31.pm9469495     Document Type: Article

References (25)

1. Eggers PW: Internal Record. Health Care Financing Administration, Washington, DC, 1992
2. Windus DW: Permanent vascular access: A nephrologist's view. Am J Kidney Dis 21:457-471, 1993
3. Windus DW, Jendrisak MD, Delmez JA: Prosthetic fistula survival and complications in hemodialysis patients: Effects of diabetes and age. Am J Kidney Dis 19:448-452, 1992
4. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA: Hemodialysis vascular access morbidity in the United States. Kidney Int 43:1091-1096, 1993
5. Churchill DN, Taylor DW, Cook RJ, LaPlante P, Barre P, Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H, McKenzie JK, Muirhead N, Parfrey PS, Posen GA, Slaughter D, Ulan RA, Werb R: Canadian hemodialysis morbidity study. Am J Kidney Dis 19:214-234, 1992
6. Muirhead N, Laupacis A, Wong C: Erythropoietin for anemia in hemodialysis patients: Results of a maintenance study. Nephrol Dial Transplant 7:811-816, 1992
7. Al-Momen AK, Huraib SO, Gader AM, Sulaimani F: Low dose danazol is effective in management of erythropoietin induced thrombosis. Thrombosis Res 64:527-532, 1991
8. Goldwasser P, Michel AM, Collier JC, Mittman N, Fein PA, Gusik SA, Avram MM: Prealbumin and lipoprotein(a) in hemodialysis: Relationships with patients and vascular access survival. Am J Kidney Dis 22:215-225, 1993
9. Windus DW: The effect of comorbid condition on hemodialysis access patency. Adv Ren Replace Ther 1:148-154, 1994
10. Obialo CI, Robinson T, Tagoe A: Focal segmental glomerulosclerosis (FSGS) predisposes to recurrent thrombosis of hemodialysis vascular access. Role of weight and urine protein excretion. J Am Soc Nephrol 7:1416, 1996 (abstr)
11. Kasiske BL, O'Donnell MD, Cleary MP, Keane SF: Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33:667-672, 1988
12. Weisinger JR, Kempson RL, Eldridge FL, Swenson RS: The nephrotic syndrome: A complication of massive obesity. Ann Intern Med 81:440-447, 1974
13. Diamond JR, Karnovsky MJ: Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. Kidney Int 33:917-924, 1988
14. Avram MM: Similarities between glomerulosclerosis and atherosclerosis in human renal biopsy specimens: A role for lipoprotein glomerulopathy. Am J Med 87:39N-41N, 1989
15. Shalhoub RJ: Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 2:556-560, 1974
16. Prakash R, Miller CC, Suki WN: Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arterio-venous graft thrombosis. Am J Kidney Dis 26:347-352, 1995
17. Prieto LN, Suki WN: Frequent hemodialysis graft thrombosis: Association with antiphospholipid antibodies. Am J Kidney Dis 23:587-590, 1994
18. Canadian Erythropoietin Study Group: Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving hemodialysis. BMJ 300:573-579, 1990
19. Tang IY, Vrahnos D, Valaitis D, Lau AH: Vascular access thrombosis during recombinant human erythropoietin therapy. ASAIO J 38:M528-531, 1992
20. Standage BA, Schuman ES, Ackerman D, Gross GF, Ragsdale JW: Does the use of erythropoietin in hemodialysis patients increase dialysis graft thrombosis rates? Am J Surg 165:650-654, 1993
21. Culp K, Flanigan M, Taylor L, Rothstein M: Vascular access thrombosis in new hemodialysis patients. Am J Kidney Dis 26:341-346, 1995
22. Fan PY, Schwab SJ: Vascular access: Concepts for the 1990's. J Am Soc Nephrol 3:1-11, 1992
23. Brock JS, Sussman M, Wamsley M, Mintzer R, Bauman FG, Riles TS: The influence of human immunodeficiency virus infection and intravenous drug abuse on complications of hemodialysis access surgery. J Vasc Surg 16:904-912, 1992
24. Palder SB, Kirkman RL, Whittemore AD, Hakim RM, Lazarus JM, Tilney NC: Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg 202:235-239, 1985
25. Raju S: PTFE grafts for hemodialysis access. Ann Surg 206:666-673, 1987